Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Revance Therapeutics Inc. buy Maxi_Scalibusa

Revance Therapeutics Inc.
Start price
€15.82
17.02.19 / 50%
Target price
€27.06
03.04.19
Performance (%)
-14.60%
End price
€13.51
03.04.19
Summary
This prediction ended on 03.04.19 with a price of €13.51. The price of Revance Therapeutics Inc. has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -14.60%. Maxi_Scalibusa has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Revance Therapeutics Inc. - - - -
iShares Core DAX® -1,06 % 5,01 % 6,60 % 64,71 %
iShares Nasdaq 100 -2,39 % 0,86 % 25,79 % 88,24 %
iShares Nikkei 225® -4,36 % 1,21 % 41,31 % 79,31 %
iShares S&P 500 -1,78 % 1,39 % 21,04 % 69,60 %

Comments by Maxi_Scalibusa for this prediction

In the thread Revance Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -14.60%
Target price 27.060
Change
Ends at 03.04.19

Revance Therapeutics

Maxi_Scalibusa 
0
Report Share
17.02.19
Prediction Buy
Perf. (%) -14.60%
Target price 27.060
Change
Ends at 03.04.19

(Stop Loss Kurs erreicht)

Maxi_Scalibusa 
0
Report Share
03.04.19